Fig 1.
Result of SLR for model design.
Table 1.
List of articles with payer or societal perspective.
Table 2.
Guidelines for NSI management.
Table 3.
HCV treatment regimen, guidelines for HCV treatment, 2018 [27].
Fig 2.
Result of SLR for parameter value.
Table 4.
Rate of needlestick injuries in multi-centre studies.
Table 5.
Needlestick injuries reporting rate in multi-centre studies.
Table 6.
HCV prevalence among patients.
Table 7.
Prevalence of HBV antibody among HCW.
Table 8.
Resource utilization.
Table 9.
Parameter base case values and values for the sensitivity analysis.
Fig 3.
Model structure.
Table 10.
Cost of needlestick injury by infectious status.
Table 11.
Cost of each items for post exposure management.
Table 12.
Cost of NSIs in Japan with reported number of NSIs per 100 beds and rate of reporting rate.
Table 13.
Cost of NSIs in Japan with prevalence of HBV and HCV among in-hospital patients.
Table 14.
Cost of NSIs in Japan with number of follow ups after NSI with risk of infection and without risk of infection.
Table 15.
Cost of needlestick injuries from the societal and a payer perspective.
Table 16.
List of Japanese studies in cost of needlestick injury.